Your browser doesn't support javascript.
loading
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Schmitt, Anja; Grimm, Melanie; Kreienkamp, Nina; Junge, Hannah; Labisch, Jan; Schuhknecht, Laurentz; Schönfeld, Caroline; Görsch, Elsa; Tibello, Alessia; Menck, Kerstin; Bleckmann, Annalen; Lengerke, Claudia; Rosenbauer, Frank; Grau, Michael; Zampieri, Mattia; Schulze-Osthoff, Klaus; Klener, Pavel; Dolnikova, Alexandra; Lenz, Georg; Hailfinger, Stephan.
Afiliação
  • Schmitt A; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Grimm M; Department of Molecular Medicine, Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
  • Kreienkamp N; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Junge H; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Labisch J; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Schuhknecht L; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Schönfeld C; Department of Molecular Medicine, Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
  • Görsch E; Department for Internal Medicine, Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Tibello A; Institute of Molecular Tumor Biology, Faculty of Medicine, University of Münster, Münster, Germany.
  • Menck K; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Bleckmann A; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Lengerke C; Department for Internal Medicine, Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
  • Rosenbauer F; Institute of Molecular Tumor Biology, Faculty of Medicine, University of Münster, Münster, Germany.
  • Grau M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.
  • Zampieri M; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Schulze-Osthoff K; Department of Molecular Medicine, Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
  • Klener P; German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung) and German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany.
  • Dolnikova A; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.
  • Lenz G; Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
  • Hailfinger S; First Department of Medicine, Hematology, University General Hospital and First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
Blood ; 142(13): 1143-1155, 2023 09 28.
Article em En | MEDLINE | ID: mdl-37294920
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Ferroptose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Ferroptose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha